Renovion
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...
top of page
News
Search
Renovion
- Apr 7, 2022
- 2 min
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...
bottom of page